Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Jacob Canick

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Physiology

Concepts & Ideas

Disorders

Procedures

Chemicals & Drugs

Anatomy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Palomaki Glenn E; Lee Jo Ellen S; Canick Jacob A; McDowell Geraldine A; Donnenfeld Alan E;
Technical standards and guidelines: prenatal screening for Down syndrome that includes first-trimester biochemistry and/or ultrasound measurements.
D'Alton M E; Cleary-Goldman J; Lambert-Messerlian G; Ball R H; Nyberg D A; Comstock C H; Bukowski R; Berkowitz R L; Dar P; Dugoff L; Craigo S D; Timor I E; Carr S R; Wolfe H M; Dukes K; Canick J A; Malone F D
Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial.
Lambert-Messerlian Geralyn; Palomaki Glenn E; Canick Jacob A
Adjustment of serum markers in first trimester screening.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Jacob Canick (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Palomaki Glenn E; Lee Jo Ellen S; Canick Jacob A; McDowell Geraldine A; Donnenfeld Alan E;
Technical standards and guidelines: prenatal screening for Down syndrome that includes first-trimester biochemistry and/or ultrasound measurements.
Genetics in medicine : official journal of the American College of Medical Genetics 2009;11(9):669-81.
2009: D'Alton M E; Cleary-Goldman J; Lambert-Messerlian G; Ball R H; Nyberg D A; Comstock C H; Bukowski R; Berkowitz R L; Dar P; Dugoff L; Craigo S D; Timor I E; Carr S R; Wolfe H M; Dukes K; Canick J A; Malone F D
Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2009;33(2):142-6.
2009: Lambert-Messerlian Geralyn; Palomaki Glenn E; Canick Jacob A
Adjustment of serum markers in first trimester screening.
Journal of medical screening 2009;16(2):102-3.
2008: Haddow James E; McClain Monica R; Lambert-Messerlian Geralyn; Palomaki Glenn E; Canick Jacob A; Cleary-Goldman Jane; Malone Fergal D; Porter T Flint; Nyberg David A; Bernstein Peter; D'Alton Mary E;
Variability in thyroid-stimulating hormone suppression by human chorionic [corrected] gonadotropin during early pregnancy.
The Journal of clinical endocrinology and metabolism 2008;93(9):3341-7.
2008: Wald Nicholas J; Bestwick Jonathan P; Canick Jacob A
Contingent screening for Down syndrome.
Prenatal diagnosis 2008;28(8):781; author reply 782.
2008: McClain Monica R; Lambert-Messerlian Geralyn; Haddow James E; Palomaki Glenn E; Canick Jacob A; Cleary-Goldman Jane; Malone Fergal D; Porter T Flint; Nyberg David A; Bernstein Peter; D'Alton Mary E;
Sequential first- and second-trimester TSH, free thyroxine, and thyroid antibody measurements in women with known hypothyroidism: a FaSTER trial study.
American journal of obstetrics and gynecology 2008;199(2):129.e1-6.
2008: Lambert-Messerlian Geralyn; McClain Monica; Haddow James E; Palomaki Glenn E; Canick Jacob A; Cleary-Goldman Jane; Malone Fergal D; Porter T Flint; Nyberg David A; Bernstein Peter; D'Alton Mary E;
First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First- and Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium study.
American journal of obstetrics and gynecology 2008;199(1):62.e1-6.
2008: Lambert-Messerlian G M; Palomaki G E; Canick J A
Inhibin A measurement using an automated assay platform.
Prenatal diagnosis 2008;28(5):399-403.
2008: Plante Beth J; Blume Jeffrey D; Lambert-Messerlian Geralyn; Shackelton Rebecca; Canick Jacob; Phipps Maureen G
A multiple marker model to predict pregnancy viability when progesterone is indeterminate.
The Journal of reproductive medicine 2008;53(4):243-9.
2008: Saller Devereux N; Canick Jacob A
Current methods of prenatal screening for Down syndrome and other fetal abnormalities.
Clinical obstetrics and gynecology 2008;51(1):24-36.
2008: Urato Adam C; Peter Inga; Canick Jacob; Lambert-Messerlian Geralyn; Pulkkinen Andrea; Knight George; Jeong Young-Ju; Johnson Kirby L; Bianchi Diana W
Smoking in pregnancy is associated with increased total maternal serum cell-free DNA levels.
Prenatal diagnosis 2008;28(3):186-90.
2008: Palomaki Glenn E; Neveux Louis M; Donnenfeld Alan; Lee Jo Ellen S; McDowell Geraldine; Canick Jacob A; Summers Anne; Lambert-Messerlian Geralyn; Kellner Leonard H; Zebelman Arthur; Haddow James E
Quality assessment of routine nuchal translucency measurements: a North American laboratory perspective.
Genetics in medicine : official journal of the American College of Medical Genetics 2008;10(2):131-8.
2007: Lambert-Messerlian Geralyn; Bandera Christina; Eklund Elizabeth; Neuhauser Andrew; Canick Jacob
Very high inhibin A concentration attributed to heterophilic antibody interference.
Clinical chemistry 2007;53(4):800-1.
2007: Nagalla Srinivasa R; Canick Jacob A; Jacob Thomas; Schneider Kimberly A; Reddy Ashok P; Thomas Archana; Dasari Surendra; Lu Xinfang; Lapidus Jodi A; Lambert-Messerlian Geralyn M; Gravett Michael G; Roberts Charles T; Luthy David; Malone Fergal D; D'Alton Mary E
Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers.
Journal of proteome research 2007;6(4):1245-57.
2007: Palomaki Glenn E; Lambert-Messerlian Geralyn M; Canick Jacob A
A summary analysis of Down syndrome markers in the late first trimester.
Advances in clinical chemistry 2007;43():177-210.
2006: Canick Jacob A; Lambert-Messerlian Geralyn M; Palomaki Glenn E; Neveux Louis M; Malone Fergal D; Ball Robert H; Nyberg David A; Comstock Christine H; Bukowski Radek; Saade George R; Berkowitz Richard L; Dar Pe'er; Dugoff Lorraine; Craigo Sabrina D; Timor-Tritsch Ilan E; Carr Stephen R; Wolfe Honor M; D'Alton Mary E;
Comparison of serum markers in first-trimester down syndrome screening.
Obstetrics and gynecology 2006;108(5):1192-9.
2006: Lambert-Messerlian G; Dugoff L; Vidaver J; Canick J A; Malone F D; Ball R H; Comstock C H; Nyberg D A; Saade G; Eddleman K; Klugman S; Craigo S D; Timor-Tritsch I E; Carr S R; Wolfe H M; D'Alton M E
First- and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study.
Prenatal diagnosis 2006;26(8):672-8.
2006: Farina Antonio; Lambert-Messerlian Geralyn M; Canick Jacob A; Banzola Irina; Carletti Angela; Concu Manuela; Tempesta Annalisa; Gabrielli Sandro; Morano Danila; Rizzo Nicola
Total activin A in maternal blood as a marker of preterm delivery in low-risk asymptomatic patients.
Prenatal diagnosis 2006;26(3):277-81.
2006: Lambert-Messerlian Geralyn M; Eklund Elizabeth E; Malone Fergal D; Palomaki Glenn E; Canick Jacob A; D'Alton Mary E
Stability of first- and second-trimester serum markers after storage and shipment.
Prenatal diagnosis 2006;26(1):17-21.
2005: Malone Fergal D; Canick Jacob A; Ball Robert H; Nyberg David A; Comstock Christine H; Bukowski Radek; Berkowitz Richard L; Gross Susan J; Dugoff Lorraine; Craigo Sabrina D; Timor-Tritsch Ilan E; Carr Stephen R; Wolfe Honor M; Dukes Kimberly; Bianchi Diana W; Rudnicka Alicja R; Hackshaw Allan K; Lambert-Messerlian Geralyn; Wald Nicholas J; D'Alton Mary E;
First-trimester or second-trimester screening, or both, for Down's syndrome.
The New England journal of medicine 2005;353(19):2001-11.
2005: Pan Phillip D; Peter Inga; Lambert-Messerlian Geralyn M; Canick Jacob A; Bianchi Diana W; Johnson Kirby L
Cell-free fetal DNA levels in pregnancies conceived by IVF.
Human reproduction (Oxford, England) 2005;20(11):3152-6.
2005: Lambert-Messerlian Geralyn M; Keren David F; Raphtis Constantine S; Byberg Krista; Canick Jacob A
Apparently low maternal serum inhibin A levels in second-trimester screening.
Prenatal diagnosis 2005;25(10):967-8.
2005: Canick Jacob A; MacRae Andrew R
Second trimester serum markers.
Seminars in perinatology 2005;29(4):203-8.
2005: Malone Fergal D; Ball Robert H; Nyberg David A; Comstock Christine H; Saade George R; Berkowitz Richard L; Gross Susan J; Dugoff Lorraine; Craigo Sabrina D; Timor-Tritsch Ilan E; Carr Stephen R; Wolfe Honor M; Dukes Kimberly; Canick Jacob A; Bianchi Diana W; D'Alton Mary E;
First-trimester septated cystic hygroma: prevalence, natural history, and pediatric outcome.
Obstetrics and gynecology 2005;106(2):288-94.
2005: Dugoff Lorraine; Hobbins John C; Malone Fergal D; Vidaver John; Sullivan Lisa; Canick Jacob A; Lambert-Messerlian Geralyn M; Porter T Flint; Luthy David A; Comstock Christine H; Saade George; Eddleman Keith; Merkatz Irwin R; Craigo Sabrina D; Timor-Tritsch Ilan E; Carr Stephen R; Wolfe Honor M; D'Alton Mary E;
Quad screen as a predictor of adverse pregnancy outcome.
Obstetrics and gynecology 2005;106(2):260-7.
2005: Lambert-Messerlian Geralyn; Pinar Halit; Rubin Lewis P; De Paepe Monique E; Tantravahi Umadevi; Steinhoff Margaret M; Russell Michelle; Canick Jacob A
Second-trimester maternal serum markers in twin pregnancy with complete mole: report of 2 cases.
Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 2005;8(2):230-4.
2004: Lambert-Messerlian Geralyn M; Canick Jacob A
Placenta growth factor levels in second-trimester maternal serum in Down syndrome pregnancy and in the prediction of preeclampsia.
Prenatal diagnosis 2004;24(11):876-80.
2004: Lambert-Messerlian G M; Pinar H; Laprade E; Tantravahi U; Schneyer A; Canick J A
Inhibins and activins in human fetal abnormalities.
Molecular and cellular endocrinology 2004;225(1-2):101-8.
2004: Lambert-Messerlian Geralyn M; Canick Jacob A
Clinical application of inhibin a measurement: prenatal serum screening for Down syndrome.
Seminars in reproductive medicine 2004;22(3):235-42.
2004: Florio P; Lambert-Messerlian G; Severi F M; Buonocore G; Canick J A; Petraglia F
Fetal neural tube defects: maternal serum and amniotic fluid activin A levels.
Prenatal diagnosis 2004;24(7):574-5.
2004: Lambert-Messerlian Geralyn; Halliday Jacquelyn; Williams Josephine; Cain Rachel; Msall Michael E; Palomaki Glenn E; Canick Jacob A
Effect of folic acid fortification on prevalence of neural tube defects in Rhode Island.
Journal of medical screening 2004;11(2):106-7.
2003: Canick Jacob A; Saller Devereux N; Lambert-Messerlian Geralyn M
Prenatal screening for Down syndrome: current and future methods.
Clinics in laboratory medicine 2003;23(2):395-411.
2003: Canick Jacob A; Kellner Leonard H; Bombard Allan T
Prenatal screening for open neural tube defects.
Clinics in laboratory medicine 2003;23(2):385-94, ix.
2003: Plevyak Michael P; Lambert-Messerlian Geralyn M; Farina Antonio; Groome Nigel P; Canick Jacob A; Silver Helayne M
Concentrations of serum total activin A and inhibin A in preterm and term labor patients: a cross-sectional study.
Journal of the Society for Gynecologic Investigation 2003;10(4):231-6.
2003: Farina Antonio; LeShane Erik S; Lambert-Messerlian Geralyn M; Canick Jacob A; Lee Thomas; Neveux Louis M; Palomaki Glenn E; Bianchi Diana W
Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy.
Clinical chemistry 2003;49(2):239-42.
2003: Wataganara Tuangsit; LeShane Erik S; Farina Antonio; Messerlian Geralyn M; Lee Thomas; Canick Jacob A; Bianchi Diana W
Maternal serum cell-free fetal DNA levels are increased in cases of trisomy 13 but not trisomy 18.
Human genetics 2003;112(2):204-8.
2003: Canick Jacob
Safety first: choices in antenatal screening for Down's syndrome.
Journal of medical screening 2003;10(2):55.
2002: Messerlian Geralyn M; Canick Jacob A
Recent advances in maternal serum screening for Down syndrome.
Medicine and health, Rhode Island 2002;85(12):362-5.
2002: Thirunavukarasu P P; Lambert-Messerlian G; Robertson D M; Dawson G; Canick J; Wallace E M
Molecular weight forms of inhibin A, inhibin B and pro-alphaC in maternal serum, amniotic fluid and placental extracts of normal and Down syndrome pregnancies.
Prenatal diagnosis 2002;22(12):1086-92.
2002: Lee Thomas; LeShane Erik S; Messerlian Geralyn M; Canick Jacob A; Farina Antonio; Heber Walter W; Bianchi Diana W
Down syndrome and cell-free fetal DNA in archived maternal serum.
American journal of obstetrics and gynecology 2002;187(5):1217-21.
2002: Silver Helayne M; Lambert-Messerlian Geralyn M; Reis Fernando M; Diblasio Anna Maria; Petraglia Felice; Canick Jacob A
Mechanism of increased maternal serum total activin a and inhibin a in preeclampsia.
Journal of the Society for Gynecologic Investigation 2002;9(5):308-12.
2001: Carpenter M W; Canick J A; Hogan J W; Shellum C; Somers M; Star J A
Amniotic fluid insulin at 14-20 weeks' gestation: association with later maternal glucose intolerance and birth macrosomia.
Diabetes care 2001;24(7):1259-63.
2001: Yasuhi I; Hogan J W; Canick J; Sosa M B; Carpenter M W
Midpregnancy serum C-peptide concentration and subsequent pregnancy-induced hypertension.
Diabetes care 2001;24(4):743-7.
2000: Goodwin K M; Sweeney P J; Lambert-Messerlian G M; Canick J A
High maternal serum inhibin A levels following the loss of one fetus in a twin pregnancy.
Prenatal diagnosis 2000;20(12):1015-7.
2000: Rausch D N; Lambert-Messerlian G M; Canick J A
Participation in maternal serum screening for Down syndrome, neural tube defects, and trisomy 18 following screen-positive results in a previous pregnancy.
The Western journal of medicine 2000;173(3):180-3.
2000: Lambert-Messerlian G M; Palomaki G E; Canick J A
Second trimester levels of maternal serum inhibin A in pregnancies affected by fetal neural tube defects.
Prenatal diagnosis 2000;20(8):680-2.
2000: Lambert-Messerlian G M; Silver H M; Petraglia F; Luisi S; Pezzani I; Maybruck W M; Hogge W A; Hanley-Yanez K; Roberts J M; Neveux L M; Canick J A
Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin a as predictors of preeclampsia in the third trimester of pregnancy.
Journal of the Society for Gynecologic Investigation 2000;7(3):170-4.
2000: Malone F D; Berkowitz R L; Canick J A; D'Alton M E
First-trimester screening for aneuploidy: research or standard of care?
American journal of obstetrics and gynecology 2000;182(3):490-6.
2000: Phipps M G; Hogan J W; Peipert J F; Lambert-Messerlian G M; Canick J A; Seifer D B
Progesterone, inhibin, and hCG multiple marker strategy to differentiate viable from nonviable pregnancies.
Obstetrics and gynecology 2000;95(2):227-31.
2000: Rausch D N; Lambert-Messerlian G M; Canick J A
Participation in maternal serum screening following screen positive results in a previous pregnancy.
Journal of medical screening 2000;7(1):4-6.
1999: Carpenter M W; Canick J A; Star J A; Shellum C; Somers M
A high-sensitivity assay for amniotic fluid insulin at 14-20 weeks' gestation.
Obstetrics and gynecology 1999;94(5 Pt 1):778-82.
1999: Canick J A; Kellner L H
First trimester screening for aneuploidy: serum biochemical markers.
Seminars in perinatology 1999;23(5):359-68.
1999: Cuckle H S; Canick J A; Kellner L H
Collaborative study of maternal urine beta -core human chorionic gonadotrophin screening for Down syndrome.
Prenatal diagnosis 1999;19(10):911-7.
1999: Saller D N; Canick J A; Blitzer M G; Palomaki G E; Schwartz S; Blakemore K J; Haddow J E
Second-trimester maternal serum analyte levels associated with fetal trisomy 13.
Prenatal diagnosis 1999;19(9):813-6.
1999: Lambert-Messerlian G M; Saller D N; Tumber M B; French C A; Peterson C J; Canick J A
Second-trimester maternal serum progesterone levels in Turner syndrome with and without hydrops and in trisomy 18.
Prenatal diagnosis 1999;19(5):476-9.
1999: Silver H M; Lambert-Messerlian G M; Star J A; Hogan J; Canick J A
Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies.
American journal of obstetrics and gynecology 1999;180(5):1131-7.
1999: Canick J A; Kellner L H; Cole L A; Cuckle H S
Urinary analyte screening: a noninvasive detection method for Down syndrome?
Molecular medicine today 1999;5(2):68-73.
1998: Lambert-Messerlian G M; Canick J A
Endocrine analytes in multiple-marker screening.
Clinics in perinatology 1998;25(4):963-81, vii.
1998: Lambert-Messerlian G M; Saller D N; Tumber M B; French C A; Peterson C J; Canick J A
Second-trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops.
Prenatal diagnosis 1998;18(10):1061-7.
1998: Canick J A; Carr S R
Screening for birth defects: integrating laboratory evaluation, genetic counseling and clinical intervention.
Medicine and health, Rhode Island 1998;81(4):122-6.
1998: Lambert-Messerlian G M; Luisi S; Florio P; Mazza V; Canick J A; Petraglia F
Second trimester levels of maternal serum total activin A and placental inhibin/activin alpha and betaA subunit messenger ribonucleic acids in Down syndrome pregnancy.
European journal of endocrinology / European Federation of Endocrine Societies 1998;138(4):425-9.
1998: Lambert-Messerlian G M; Canick J A; Melegos D N; Diamandis E P
Increased concentrations of prostate-specific antigen in maternal serum from pregnancies affected by fetal Down syndrome.
Clinical chemistry 1998;44(2):205-8.
1997: Kellner L H; Canick J A; Palomaki G E; Neveux L M; Saller D N; Walker R P; Osathanondh R; Bombard A T
Levels of urinary beta-core fragment, total oestriol, and the ratio of the two in second-trimester screening for Down syndrome.
Prenatal diagnosis 1997;17(12):1135-41.
1997: Saller D N; Canick J A; Kellner L H; Rose N C; Garza J; French C A; Mooney R A
Maternal serum analyte levels in pregnancies with fetal Down syndrome resulting from translocations.
American journal of obstetrics and gynecology 1997;177(4):879-81.
1997: Cole L A; Kellner L H; Isozaki T; Palomaki G E; Iles R K; Walker R P; Ozaki M; Canick J A
Comparison of 12 assays for detecting hCG and related molecules in urine samples from Down syndrome pregnancies.
Prenatal diagnosis 1997;17(7):607-14.
1997: Frishman G N; Canick J A; Hogan J W; Hackett R J; Kellner L H; Saller D N
Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies.
Obstetrics and gynecology 1997;90(1):98-101.
1997: Lambert-Messerlian G M; Steinhoff M; Zheng W; Canick J A; Gajewski W H; Seifer D B; Schneyer A L
Multiple immunoreactive inhibin proteins in serum from postmenopausal women with epithelial ovarian cancer.
Gynecologic oncology 1997;65(3):512-6.
1997: Star J; Canick J A; Palomaki G E; Carpenter M W; Saller D N; Sung C J; Tumber M B; Coustan D R
The relationship between second-trimester amniotic fluid insulin and glucose levels and subsequent gestational diabetes.
Prenatal diagnosis 1997;17(2):149-54.
1996: Cole L; Isozaki T; Palomaki G; Canick J; Iles R; Kellner L; Saller D; Cuckle H
Detection of beta-core fragment in second trimester Down's syndrome pregnancies.
Early human development 1996;47 Suppl():S47-8.
1996: Cuckle H S; Canick J A; Kellner L H; Van Lith J M; White I; Helbig B R; Rose N C; Sehmi I K; Jones R
Urinary beta-core-hCG screening in the first trimester.
Prenatal diagnosis 1996;16(11):1057-9.
1996: Haning R V; Tantravahi U; Zhao Q; Hackett R J; Canick J A
5alpha-reductase 1 and 2 expression and activity in human ovarian follicles, stroma and corpus luteum as compared to neonatal foreskin.
The Journal of steroid biochemistry and molecular biology 1996;59(2):199-204.
1996: Saller D N; Canick J A; Oyer C E
The detection of non-immune hydrops through second-trimester maternal serum screening.
Prenatal diagnosis 1996;16(5):431-5.
1996: Seifer D B; Lambert-Messerlian G M; Canick J A; Frishman G N; Schneyer A L
Serum inhibin levels are lower in ectopic than intrauterine spontaneously conceived pregnancies.
Fertility and sterility 1996;65(3):667-9.
1996: Saller D N; Oyer C E; Star J; Canick J A
A normative study of obstetric complications associated with fetal trisomy 18.
Journal of perinatology : official journal of the California Perinatal Association 1996;16(2 Pt 1):117-20; quiz 121-2.
1996: Haning R V; Canick J A; Goldsmith L T; Shahinian K A; Erinakes N J; Weiss G
The effect of ovulation induction on the concentration of maternal serum relaxin in twin pregnancies.
American journal of obstetrics and gynecology 1996;174(1 Pt 1):227-32.
1996: Carpenter M W; Canick J A; Star J; Carr S R; Burke M E; Shahinian K
Fetal hyperinsulinism at 14-20 weeks and subsequent gestational diabetes.
Obstetrics and gynecology 1996;87(1):89-93.
1996: Lambert-Messerlian G M; Canick J A; Palomaki G E
Maternal serum total activin A in pregnancies affected with fetal Down's syndrome.
Journal of medical screening 1996;3(4):217.
1996: Lambert-Messerlian G M; Canick J A; Palomaki G E; Schneyer A L
Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancy.
Journal of medical screening 1996;3(2):58-62.
1995: Canick J A; Kellner L H; Saller D N; Palomaki G E; Walker R P; Osathanondh R
Second-trimester levels of maternal urinary gonadotropin peptide in Down syndrome pregnancy.
Prenatal diagnosis 1995;15(8):739-44.
1995: Palomaki G E; Haddow J E; Knight G J; Wald N J; Kennard A; Canick J A; Saller D N; Blitzer M G; Dickerman L H; Fisher R
Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin.
Prenatal diagnosis 1995;15(8):713-23.
1994: Saller D N; Canick J A; Palomaki G E; Knight G J; Haddow J E
Second-trimester maternal serum alpha-fetoprotein, unconjugated estriol, and hCG levels in pregnancies with ventral wall defects.
Obstetrics and gynecology 1994;84(5):852-5.
1994: Rose N C; Canick J A; Knight G J; Pulkkinen A; Tumber M B; Mennuti M T; Palomaki G E
Second-trimester diurnal variation of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol: is it present and does it affect the prediction of a patient's risk for fetal Down syndrome?
Prenatal diagnosis 1994;14(10):947-51.
1993: Neiger R; Wise C; Contag S A; Tumber M B; Canick J A
First trimester bleeding and pregnancy outcome in gravidas with normal and low folate levels.
American journal of perinatology 1993;10(6):460-2.
1993: Saller D N; Rogers B B; Canick J A
Maternal serum biochemical markers in pregnancies with fetal parvovirus B19 infection.
Prenatal diagnosis 1993;13(6):467-71.
1993: Saller D N; Dailey J V; Doyle D L; Carr S R; Canick J A; Rogers B B
Turner syndrome associated with an omphalocele.
Prenatal diagnosis 1993;13(5):424-6.
1993: Palomaki G E; Knight G J; Haddow J E; Canick J A; Wald N J; Kennard A
Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on Down syndrome screening.
Obstetrics and gynecology 1993;81(5 ( Pt 1)):675-8.
1992: Palomaki G E; Knight G J; Haddow J E; Canick J A; Saller D N; Panizza D S
Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin.
Prenatal diagnosis 1992;12(11):925-30.
1992: Saller D N; Canick J A; Schwartz S; Blitzer M G
Multiple-marker screening in pregnancies with hydropic and nonhydropic Turner syndrome.
American journal of obstetrics and gynecology 1992;167(4 Pt 1):1021-4.
1992: Haddow J E; Palomaki G E; Knight G J; Williams J; Pulkkinen A; Canick J A; Saller D N; Bowers G B
Prenatal screening for Down's syndrome with use of maternal serum markers.
The New England journal of medicine 1992;327(9):588-93.
1992: Oyer C E; Canick J A
Maternal serum hCG levels in triploidy: variability and need to consider molar tissue.
Prenatal diagnosis 1992;12(7):627-9.
1992: Haning R V; Hackett R J; Canick J A
Steroid sulfatase in the human ovary and placenta: enzyme kinetics and phosphate inhibition.
The Journal of steroid biochemistry and molecular biology 1992;41(2):161-5.
1990: Canick J A; Knight G J; Palomaki G E; Haddow J E
Second-trimester levels of maternal serum unconjugated oestriol and human chorionic gonadotropin in pregnancies affected by fetal anencephaly and open spina bifida.
Prenatal diagnosis 1990;10(11):733-7.
1990: Canick J A; Palomaki G E; Osathanondh R
Prenatal screening for trisomy 18 in the second trimester.
Prenatal diagnosis 1990;10(8):546-8.
1990: Haning R V; Hackett R J; Boothroid R I; Canick J A
Steroid sulphatase activity in the human ovarian corpus luteum, stroma, and follicle: comparison to activity in other tissues and the placenta.
Journal of steroid biochemistry 1990;36(1-2):175-9.
1988: Canick J A; Knight G J; Palomaki G E; Haddow J E; Cuckle H S; Wald N J
Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome.
British journal of obstetrics and gynaecology 1988;95(4):330-3.
1987: Canick J A; Tobet S A; Baum M J; Vaccaro D E; Ryan K J; Leeman S E; Fox T O
Studies on the role of catecholamines in the regulation of the developmental pattern of hypothalamic aromatase.
Steroids 1987;50(4-6):509-21.
1986: Canick J A; Vaccaro D E; Livingston E M; Leeman S E; Ryan K J; Fox T O
Localization of aromatase and 5 alpha-reductase to neuronal and non-neuronal cells in the fetal rat hypothalamus.
Brain research 1986;372(2):277-82.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Jacob Canick

Research Profile (preview)

Physiology

Concepts & Ideas

Disorders

Procedures

Chemicals & Drugs

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Jacob Canick (preview)

All Publications